Cryo Cell International (CCEL) Asset Writedowns and Impairment (2010 - 2026)
Cryo Cell International (CCEL) reported Asset Writedowns and Impairment of $213341.0 for Q1 2026, down 21.34% year-over-year from $271207.0 in Q1 2025, and down 95.11% quarter-over-quarter from $4.4 million in Q4 2025.
Cryo Cell International (CCEL) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has 17 years of Asset Writedowns and Impairment data on file, last reported at $213341.0 in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $213341.0, down 21.34% year-over-year; the trailing twelve-month figure through Feb 2026 was $4.3 million (up 1380.81% YoY), and the FY2024 annual result was $308000.0, down 64.55% from the prior year.
- Asset Writedowns and Impairment slipped to $213341.0 in Q1 2026 per CCEL's latest filing, from $4.4 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $4.4 million in Q4 2025 and troughed at -$634405.0 in Q4 2022.
- A 5-year average of $666740.0 and a median of $225294.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment jumped 1533.03% in 2022, then slumped 1509.6% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at -$634405.0 in 2022, then jumped by 689.08% to $3.7 million in 2023, then sank by 99.49% to $19240.0 in 2024, then jumped by 22555.06% to $4.4 million in 2025, then tumbled by 95.11% to $213341.0 in 2026.
- Business Quant data shows CCEL's Asset Writedowns and Impairment at $213341.0 in Q1 2026, $4.4 million in Q4 2025, and -$271207.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | Cryo Cell International | 29.64 Mn | 26.74 Mn | 6.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 213,341.00 |
| Feb 28, 2026 | 213,341.00 |
| Nov 30, 2025 | 4.36 Mn |
| Nov 30, 2025 | 4.36 Mn |
| May 31, 2025 | -271,207.00 |
| May 31, 2025 | -271,207.00 |
| Feb 28, 2025 | 271,207.00 |
| Feb 28, 2025 | 271,207.00 |
| May 31, 2024 | 19,240.00 |
| May 31, 2024 | 19,240.00 |
| Feb 29, 2024 | 288,760.00 |
| Feb 29, 2024 | 288,760.00 |
| Nov 30, 2023 | 3.74 Mn |
| Nov 30, 2023 | 3.74 Mn |
| Aug 31, 2023 | 314,012.00 |
| Aug 31, 2023 | 314,012.00 |
| May 31, 2023 | 216,136.00 |
| May 31, 2023 | 216,136.00 |
| Feb 28, 2023 | 186,904.00 |
| Feb 28, 2023 | 186,904.00 |